img

Global Solid Tumor Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Solid Tumor Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Solid Tumor Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Solid Tumor Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Neurology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Solid Tumor Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Solid Tumor Drug key manufacturers include AstraZeneca, Biogen, Baxter, Celgene Corporation, Abbott Laboratories, Pfizer Inc, Amgen Limited & Amgen Ireland Limited, Bristol-Myers Squibb Company and GlaxoSmithKline plc., etc. AstraZeneca, Biogen, Baxter are top 3 players and held % sales share in total in 2022.
Solid Tumor Drug can be divided into Small Molecules and Biologics, etc. Small Molecules is the mainstream product in the market, accounting for % sales share globally in 2022.
Solid Tumor Drug is widely used in various fields, such as Oncology, Neurology, Radiology and Others, etc. Oncology provides greatest supports to the Solid Tumor Drug industry development. In 2022, global % sales of Solid Tumor Drug went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Solid Tumor Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Biogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
Segment by Type
Small Molecules
Biologics

Segment by Application


Oncology
Neurology
Radiology
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Solid Tumor Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Solid Tumor Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Solid Tumor Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Solid Tumor Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Solid Tumor Drug introduction, etc. Solid Tumor Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Solid Tumor Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Solid Tumor Drug Market Overview
1.1 Solid Tumor Drug Product Overview
1.2 Solid Tumor Drug Market Segment by Type
1.2.1 Small Molecules
1.2.2 Biologics
1.3 Global Solid Tumor Drug Market Size by Type
1.3.1 Global Solid Tumor Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Solid Tumor Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Solid Tumor Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Solid Tumor Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Solid Tumor Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Solid Tumor Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Solid Tumor Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Solid Tumor Drug Sales Breakdown by Type (2018-2024)
2 Global Solid Tumor Drug Market Competition by Company
2.1 Global Top Players by Solid Tumor Drug Sales (2018-2024)
2.2 Global Top Players by Solid Tumor Drug Revenue (2018-2024)
2.3 Global Top Players by Solid Tumor Drug Price (2018-2024)
2.4 Global Top Manufacturers Solid Tumor Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Solid Tumor Drug Market Competitive Situation and Trends
2.5.1 Solid Tumor Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Solid Tumor Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Solid Tumor Drug Market
2.8 Key Manufacturers Solid Tumor Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Solid Tumor Drug Status and Outlook by Region
3.1 Global Solid Tumor Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Solid Tumor Drug Historic Market Size by Region
3.2.1 Global Solid Tumor Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Solid Tumor Drug Sales in Value by Region (2018-2024)
3.2.3 Global Solid Tumor Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Solid Tumor Drug Forecasted Market Size by Region
3.3.1 Global Solid Tumor Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Solid Tumor Drug Sales in Value by Region (2024-2034)
3.3.3 Global Solid Tumor Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Solid Tumor Drug by Application
4.1 Solid Tumor Drug Market Segment by Application
4.1.1 Oncology
4.1.2 Neurology
4.1.3 Radiology
4.1.4 Others
4.2 Global Solid Tumor Drug Market Size by Application
4.2.1 Global Solid Tumor Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Solid Tumor Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Solid Tumor Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Solid Tumor Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Solid Tumor Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Solid Tumor Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Solid Tumor Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Solid Tumor Drug Sales Breakdown by Application (2018-2024)
5 North America Solid Tumor Drug by Country
5.1 North America Solid Tumor Drug Historic Market Size by Country
5.1.1 North America Solid Tumor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Solid Tumor Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Solid Tumor Drug Sales in Value by Country (2018-2024)
5.2 North America Solid Tumor Drug Forecasted Market Size by Country
5.2.1 North America Solid Tumor Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Solid Tumor Drug Sales in Value by Country (2024-2034)
6 Europe Solid Tumor Drug by Country
6.1 Europe Solid Tumor Drug Historic Market Size by Country
6.1.1 Europe Solid Tumor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Solid Tumor Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Solid Tumor Drug Sales in Value by Country (2018-2024)
6.2 Europe Solid Tumor Drug Forecasted Market Size by Country
6.2.1 Europe Solid Tumor Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Solid Tumor Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Solid Tumor Drug by Region
7.1 Asia-Pacific Solid Tumor Drug Historic Market Size by Region
7.1.1 Asia-Pacific Solid Tumor Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Solid Tumor Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Solid Tumor Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Solid Tumor Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Solid Tumor Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Solid Tumor Drug Sales in Value by Region (2024-2034)
8 Latin America Solid Tumor Drug by Country
8.1 Latin America Solid Tumor Drug Historic Market Size by Country
8.1.1 Latin America Solid Tumor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Solid Tumor Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Solid Tumor Drug Sales in Value by Country (2018-2024)
8.2 Latin America Solid Tumor Drug Forecasted Market Size by Country
8.2.1 Latin America Solid Tumor Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Solid Tumor Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Solid Tumor Drug by Country
9.1 Middle East and Africa Solid Tumor Drug Historic Market Size by Country
9.1.1 Middle East and Africa Solid Tumor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Solid Tumor Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Solid Tumor Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Solid Tumor Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Solid Tumor Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Solid Tumor Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AstraZeneca Solid Tumor Drug Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Biogen
10.2.1 Biogen Company Information
10.2.2 Biogen Introduction and Business Overview
10.2.3 Biogen Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biogen Solid Tumor Drug Products Offered
10.2.5 Biogen Recent Development
10.3 Baxter
10.3.1 Baxter Company Information
10.3.2 Baxter Introduction and Business Overview
10.3.3 Baxter Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Baxter Solid Tumor Drug Products Offered
10.3.5 Baxter Recent Development
10.4 Celgene Corporation
10.4.1 Celgene Corporation Company Information
10.4.2 Celgene Corporation Introduction and Business Overview
10.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Celgene Corporation Solid Tumor Drug Products Offered
10.4.5 Celgene Corporation Recent Development
10.5 Abbott Laboratories
10.5.1 Abbott Laboratories Company Information
10.5.2 Abbott Laboratories Introduction and Business Overview
10.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Abbott Laboratories Solid Tumor Drug Products Offered
10.5.5 Abbott Laboratories Recent Development
10.6 Pfizer Inc
10.6.1 Pfizer Inc Company Information
10.6.2 Pfizer Inc Introduction and Business Overview
10.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Pfizer Inc Solid Tumor Drug Products Offered
10.6.5 Pfizer Inc Recent Development
10.7 Amgen Limited & Amgen Ireland Limited
10.7.1 Amgen Limited & Amgen Ireland Limited Company Information
10.7.2 Amgen Limited & Amgen Ireland Limited Introduction and Business Overview
10.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Products Offered
10.7.5 Amgen Limited & Amgen Ireland Limited Recent Development
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Company Information
10.8.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bristol-Myers Squibb Company Solid Tumor Drug Products Offered
10.8.5 Bristol-Myers Squibb Company Recent Development
10.9 GlaxoSmithKline plc.
10.9.1 GlaxoSmithKline plc. Company Information
10.9.2 GlaxoSmithKline plc. Introduction and Business Overview
10.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline plc. Solid Tumor Drug Products Offered
10.9.5 GlaxoSmithKline plc. Recent Development
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 F. Hoffmann-La Roche Ltd. Company Information
10.10.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Products Offered
10.10.5 F. Hoffmann-La Roche Ltd. Recent Development
10.11 Eli Lilly and Company
10.11.1 Eli Lilly and Company Company Information
10.11.2 Eli Lilly and Company Introduction and Business Overview
10.11.3 Eli Lilly and Company Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Eli Lilly and Company Solid Tumor Drug Products Offered
10.11.5 Eli Lilly and Company Recent Development
10.12 Johnson & Johnson
10.12.1 Johnson & Johnson Company Information
10.12.2 Johnson & Johnson Introduction and Business Overview
10.12.3 Johnson & Johnson Solid Tumor Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Johnson & Johnson Solid Tumor Drug Products Offered
10.12.5 Johnson & Johnson Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Solid Tumor Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Solid Tumor Drug Industrial Chain Analysis
11.4 Solid Tumor Drug Market Dynamics
11.4.1 Solid Tumor Drug Industry Trends
11.4.2 Solid Tumor Drug Market Drivers
11.4.3 Solid Tumor Drug Market Challenges
11.4.4 Solid Tumor Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Solid Tumor Drug Distributors
12.3 Solid Tumor Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Small Molecules
Table 2. Major Company of Biologics
Table 3. Global Solid Tumor Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Solid Tumor Drug Sales by Type (2018-2024) & (K MT)
Table 5. Global Solid Tumor Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Solid Tumor Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Solid Tumor Drug Market Share in Value by Type (2018-2024)
Table 8. Global Solid Tumor Drug Price by Type (2018-2024) & (USD/MT)
Table 9. Global Solid Tumor Drug Sales by Type (2024-2034) & (K MT)
Table 10. Global Solid Tumor Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Solid Tumor Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Solid Tumor Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Solid Tumor Drug Price by Type (2024-2034) & (USD/MT)
Table 14. North America Solid Tumor Drug Sales by Type (2018-2024) & (K MT)
Table 15. North America Solid Tumor Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Solid Tumor Drug Sales (K MT) by Type (2018-2024)
Table 17. Europe Solid Tumor Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Solid Tumor Drug Sales (K MT) by Type (2018-2024)
Table 19. Asia-Pacific Solid Tumor Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Solid Tumor Drug Sales (K MT) by Type (2018-2024)
Table 21. Latin America Solid Tumor Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Solid Tumor Drug Sales (K MT) by Type (2018-2024)
Table 23. Middle East and Africa Solid Tumor Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Solid Tumor Drug Sales by Company (2018-2024) & (K MT)
Table 25. Global Solid Tumor Drug Sales Share by Company (2018-2024)
Table 26. Global Solid Tumor Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Solid Tumor Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Solid Tumor Drug Price by Company (2018-2024) & (USD/MT)
Table 29. Global Solid Tumor Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Solid Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Solid Tumor Drug Market
Table 33. Key Manufacturers Solid Tumor Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Solid Tumor Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Solid Tumor Drug Sales by Region (2018-2024) & (K MT)
Table 37. Global Solid Tumor Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Solid Tumor Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Solid Tumor Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 41. Global Solid Tumor Drug Sales by Region (2024-2034) & (K MT)
Table 42. Global Solid Tumor Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Solid Tumor Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Solid Tumor Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 46. Global Solid Tumor Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Solid Tumor Drug Sales by Application (2018-2024) & (K MT)
Table 48. Global Solid Tumor Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Solid Tumor Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Solid Tumor Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Solid Tumor Drug Price by Application (2018-2024) & (USD/MT)
Table 52. Global Solid Tumor Drug Sales by Application (2024-2034) & (K MT)
Table 53. Global Solid Tumor Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Solid Tumor Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Solid Tumor Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Solid Tumor Drug Price by Application (2024-2034) & (USD/MT)
Table 57. North America Solid Tumor Drug Sales by Application (2018-2024) (K MT)
Table 58. North America Solid Tumor Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Solid Tumor Drug Sales by Application (2018-2024) (K MT)
Table 60. Europe Solid Tumor Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Solid Tumor Drug Sales by Application (2018-2024) (K MT)
Table 62. Asia-Pacific Solid Tumor Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Solid Tumor Drug Sales by Application (2018-2024) (K MT)
Table 64. Latin America Solid Tumor Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Solid Tumor Drug Sales by Application (2018-2024) (K MT)
Table 66. Middle East and Africa Solid Tumor Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Solid Tumor Drug Sales by Country (2018-2024) & (K MT)
Table 68. North America Solid Tumor Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Solid Tumor Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Solid Tumor Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Solid Tumor Drug Sales by Country (2024-2034) & (K MT)
Table 72. North America Solid Tumor Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Solid Tumor Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Solid Tumor Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Solid Tumor Drug Sales by Country (2018-2024) & (K MT)
Table 76. Europe Solid Tumor Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Solid Tumor Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Solid Tumor Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Solid Tumor Drug Sales by Country (2024-2034) & (K MT)
Table 80. Europe Solid Tumor Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Solid Tumor Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Solid Tumor Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Solid Tumor Drug Sales by Region (2018-2024) & (K MT)
Table 84. Asia-Pacific Solid Tumor Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Solid Tumor Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Solid Tumor Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Solid Tumor Drug Sales by Region (2024-2034) & (K MT)
Table 88. Asia-Pacific Solid Tumor Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Solid Tumor Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Solid Tumor Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Solid Tumor Drug Sales by Country (2018-2024) & (K MT)
Table 92. Latin America Solid Tumor Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Solid Tumor Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Solid Tumor Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Solid Tumor Drug Sales by Country (2024-2034) & (K MT)
Table 96. Latin America Solid Tumor Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Solid Tumor Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Solid Tumor Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Solid Tumor Drug Sales by Country (2018-2024) & (K MT)
Table 100. Middle East and Africa Solid Tumor Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Solid Tumor Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Solid Tumor Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Solid Tumor Drug Sales by Country (2024-2034) & (K MT)
Table 104. Middle East and Africa Solid Tumor Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Solid Tumor Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Solid Tumor Drug Sales Market Share in Value by Country (2024-2034)
Table 107. AstraZeneca Company Information
Table 108. AstraZeneca Introduction and Business Overview
Table 109. AstraZeneca Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. AstraZeneca Solid Tumor Drug Product
Table 111. AstraZeneca Recent Development
Table 112. Biogen Company Information
Table 113. Biogen Introduction and Business Overview
Table 114. Biogen Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Biogen Solid Tumor Drug Product
Table 116. Biogen Recent Development
Table 117. Baxter Company Information
Table 118. Baxter Introduction and Business Overview
Table 119. Baxter Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Baxter Solid Tumor Drug Product
Table 121. Baxter Recent Development
Table 122. Celgene Corporation Company Information
Table 123. Celgene Corporation Introduction and Business Overview
Table 124. Celgene Corporation Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Celgene Corporation Solid Tumor Drug Product
Table 126. Celgene Corporation Recent Development
Table 127. Abbott Laboratories Company Information
Table 128. Abbott Laboratories Introduction and Business Overview
Table 129. Abbott Laboratories Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Abbott Laboratories Solid Tumor Drug Product
Table 131. Abbott Laboratories Recent Development
Table 132. Pfizer Inc Company Information
Table 133. Pfizer Inc Introduction and Business Overview
Table 134. Pfizer Inc Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Pfizer Inc Solid Tumor Drug Product
Table 136. Pfizer Inc Recent Development
Table 137. Amgen Limited & Amgen Ireland Limited Company Information
Table 138. Amgen Limited & Amgen Ireland Limited Introduction and Business Overview
Table 139. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product
Table 141. Amgen Limited & Amgen Ireland Limited Recent Development
Table 142. Bristol-Myers Squibb Company Company Information
Table 143. Bristol-Myers Squibb Company Introduction and Business Overview
Table 144. Bristol-Myers Squibb Company Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Bristol-Myers Squibb Company Solid Tumor Drug Product
Table 146. Bristol-Myers Squibb Company Recent Development
Table 147. GlaxoSmithKline plc. Company Information
Table 148. GlaxoSmithKline plc. Introduction and Business Overview
Table 149. GlaxoSmithKline plc. Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. GlaxoSmithKline plc. Solid Tumor Drug Product
Table 151. GlaxoSmithKline plc. Recent Development
Table 152. F. Hoffmann-La Roche Ltd. Company Information
Table 153. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 154. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product
Table 156. F. Hoffmann-La Roche Ltd. Recent Development
Table 157. Eli Lilly and Company Company Information
Table 158. Eli Lilly and Company Introduction and Business Overview
Table 159. Eli Lilly and Company Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 160. Eli Lilly and Company Solid Tumor Drug Product
Table 161. Eli Lilly and Company Recent Development
Table 162. Johnson & Johnson Company Information
Table 163. Johnson & Johnson Introduction and Business Overview
Table 164. Johnson & Johnson Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 165. Johnson & Johnson Solid Tumor Drug Product
Table 166. Johnson & Johnson Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Solid Tumor Drug Market Trends
Table 170. Solid Tumor Drug Market Drivers
Table 171. Solid Tumor Drug Market Challenges
Table 172. Solid Tumor Drug Market Restraints
Table 173. Solid Tumor Drug Distributors List
Table 174. Solid Tumor Drug Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Solid Tumor Drug Product Picture
Figure 2. Global Solid Tumor Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Solid Tumor Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Solid Tumor Drug Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Small Molecules
Figure 6. Global Small Molecules Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Biologics
Figure 8. Global Biologics Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Global Solid Tumor Drug Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Solid Tumor Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Solid Tumor Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Solid Tumor Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Solid Tumor Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Solid Tumor Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Solid Tumor Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Solid Tumor Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Solid Tumor Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Solid Tumor Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Solid Tumor Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Solid Tumor Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Solid Tumor Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Solid Tumor Drug Revenue in 2022
Figure 23. Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Oncology
Figure 25. Global Oncology Sales YoY Growth (2018-2034) & (K MT)
Figure 26. Product Picture of Neurology
Figure 27. Global Neurology Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Radiology
Figure 29. Global Radiology Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Global Solid Tumor Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Solid Tumor Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Solid Tumor Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Solid Tumor Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Solid Tumor Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Solid Tumor Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Solid Tumor Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Solid Tumor Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Solid Tumor Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Solid Tumor Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Solid Tumor Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Solid Tumor Drug Manufacturing Cost Structure
Figure 45. Solid Tumor Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries